Swarna Prashana in Ayurveda
Childhood is a critical phase of physical, cognitive and immunological development, during which adequate nutrition, preventive healthcare and protection against infections play an essential role in maintaining overall health. Ayurveda describes several traditional approaches to paediatric healthcare (Kaumarabhritya), among which Swarna Prashana (oral administration of processed gold) holds a distinctive position.1 Traditionally, it is considered a health-promoting intervention intended to support immunity, intellect, digestion, metabolism and physical strength in children.
The practice is described in the Kashyapa Samhita, an important classical Ayurvedic text on paediatrics, under the concept of Lehana (administration of medicinal preparations in lickable form). It involves administering processed gold, traditionally combined with honey (Madhu) and clarified butter (Ghrita). Its traditional applications have generated interest in exploring its potential immunomodulatory and developmental effects through contemporary scientific research.
Classical principles and therapeutic significance
According to Ayurvedic literature, Swarna Prashana is traditionally associated with improvements in Medha (intellect), Agni (digestion and metabolism), Bala (physical strength and immunity) and Ayushya (longevity).2 Acharya Kashyapa described its potential benefits in supporting physical development, cognitive functions and resistance against diseases. It is also considered a form of preventive healthcare that may contribute to maintaining children's overall well-being.
The preparation is traditionally classified under Jatakarma Samskara (newborn care) and Lehana (supplementary medicinal feeding). The formulation and duration of administration vary across classical descriptions. The traditional emphasis is on using properly purified and processed gold rather than unprocessed metallic gold.
Formulation and its ingredients
The commonly described Swarna Prashana preparation contains Swarna Bhasma (processed gold), Madhu (honey) and Ghrita (clarified butter). Certain formulations also incorporate medicinal herbs traditionally recognised for their Medhya (cognition-supporting) and Rasayana (rejuvenative) properties. The composition may vary depending on the classical reference and the specific formulation adopted by the practitioner.
Swarna Bhasma is prepared through specialised pharmaceutical processing procedures (Shodhana and Marana) intended to transform gold into a suitable medicinal preparation. Ghrita is traditionally regarded as a carrier (Yogavahi) that supports the delivery of medicinal substances, while Madhu is valued for its traditional therapeutic and formulation-related properties. However, the physicochemical characteristics, purity and safety of the final preparation depend on its manufacturing process and quality-control standards.
Exploring the potential immunomodulatory effects
One of the major areas of scientific interest surrounding Swarna Prashana is its potential influence on immune function. Traditional Ayurvedic descriptions associate the preparation with Vyadhikshamatva (disease resistance). Contemporary research has investigated changes in immunological parameters, including immunoglobulin levels, to explore this traditional application.
A randomised, controlled, single-blind clinical trial by Bhaskaran and colleagues evaluated Swarna Prashana in 102 healthy infants. Participants received either a combination of Swarna Bhasma, honey and Ghrita, or honey and Ghrita alone, for four weeks, followed by an eight-week observation period. The study reported no significant differences between the groups in anthropometric and biochemical parameters, suggesting that the intervention did not adversely affect normal growth or the measured biochemical indicators during the study period. Although changes in immunoglobulin G (IgG) levels were observed within both groups, the between-group difference was not statistically significant. The authors also reported findings suggestive of possible immunomodulatory activity based on their secondary analysis.
Potential role in cognitive and physical development
The traditional use of Swarna Prashana also extends to supporting cognitive development, memory and learning abilities.3 Its association with Medha and Buddhi (intellectual functions) has encouraged investigations into its potential neurocognitive effects. Certain formulations combine processed gold with herbs traditionally classified as Medhya Rasayana, including Brahmi (Bacopa monnieri), Shankhapushpi (Convolvulus pluricaulis) and Yashtimadhu (Glycyrrhiza glabra).
These herbs have been investigated individually for their potential neuroprotective, antioxidant and cognition-related properties. However, the contribution of each ingredient to the overall effects of a combined Swarna Prashana formulation remains unclear. Claims regarding improvements in intelligence quotient (IQ), memory and academic performance require confirmation through adequately powered, standardised clinical trials.
Evidence from published clinical research
Published Ayurvedic literature includes clinical investigations and reviews exploring the potential health benefits of Swarna Prashana in children. A scoping review by Antony and colleagues, published in Annals of Ayurvedic Medicine in 2021, evaluated 10 studies identified from seven electronic databases. The review reported that Swarna Prashana was consistently associated with improvements in weight and reductions in illness episodes across the included studies. However, the authors highlighted considerable heterogeneity in study design, participant age groups and outcome measurements. They also emphasised the need for larger, population-specific studies to establish its effects on immunity and cognitive functions.
Similarly, a systematic review published clinical studies evaluating Swarnaprashana in children. The authors explored its potential applications in paediatric healthcare, particularly in relation to immunity and overall development. Such reviews indicate growing research interest in the practice, although variations in formulation, dosage, administration schedules and clinical assessment limit the generalisability of the available findings.
Safety considerations and clinical limitations
Despite its traditional applications, the safety of Swarna Prashana requires careful consideration, particularly because it is intended for use in infants and young children. The quality of Swarna Bhasma, manufacturing procedures, particle characteristics, elemental composition and potential contamination with toxic metals are important considerations. Standardised pharmaceutical preparation and appropriate testing for heavy metals, microbial contamination and batch consistency are essential before clinical use.
The randomised controlled trial involving 102 infants reported no adverse effects during the intervention and follow-up periods. However, its relatively short duration and limited sample size do not establish long-term safety across different paediatric age groups. Moreover, honey-containing preparations must not be administered to infants below 12 months because of the risk of infant botulism. The absence of established, universally accepted paediatric dosing and long-term safety data further warrants caution.
Integrating traditional practice with modern paediatric care
Swarna Prashana may be explored as a traditional Ayurvedic health-promoting intervention, but it should not replace evidence-based paediatric preventive healthcare. Childhood immunisation, balanced nutrition, adequate sleep, physical activity, developmental monitoring and timely management of infections remain essential components of child health. Its administration should only be considered after appropriate assessment by qualified healthcare professionals, with attention to the preparation's quality, ingredients and age-related safety.
Further randomised controlled trials with larger sample sizes, standardised formulations, clearly defined outcome measures and extended follow-up are needed to establish its clinical effectiveness. Research should particularly examine immunological responses, growth parameters, cognitive development, adverse effects and possible interactions with other medications.
Conclusion
Swarna Prashana represents a distinctive traditional Ayurvedic approach to childhood healthcare, with classical applications related to immunity, cognition, digestion and physical development. Preliminary clinical investigations have explored its immunomodulatory potential and safety, but the available evidence remains limited by small study populations, heterogeneous formulations and short follow-up periods. Further rigorous clinical research and pharmaceutical standardisation are necessary to establish its therapeutic value and long-term safety. Integrating traditional Ayurvedic knowledge with evidence-based paediatric practices may help clarify its appropriate role in preventive child healthcare.
References:
- Jyothy KB, Sheshagiri S, Patel KS, Rajagopala S. A critical appraisal on Swarnaprashana in children. Ayu. 2014;35(4):361-365. doi:10.4103/0974-8520.158978. https://pmc.ncbi.nlm.nih.gov/articles/PMC4492018/
- Nelaturi P, Nagarajan P, Sabapathy SK, Sambandam R. Swarna Bindu Prashana-an Ancient Approach to Improve the Infant's Immunity. Biol Trace Elem Res. 2021;199(6):2145-2148. doi:10.1007/s12011-020-02353-y. https://pmc.ncbi.nlm.nih.gov/articles/PMC7451701/
- Raj A; From the proceedings of Insight Ayurveda 2013, Coimbatore. 24th and 25th May 2013. OA03.10. Public health initiative on swarnamrita prashana: A multicentric trial. Anc Sci Life. 2013;32(Suppl 2):S33. doi:10.4103/0257-7941.123847. https://pmc.ncbi.nlm.nih.gov/articles/PMC4147503/